hiv-infections

Documents about hiv-infections

• Decision-making pathways of voluntary sexual partner disclosure among newly diagnosed people living with HIV: a qualitative study informed by the health belief model.#313077PubMed
• A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children#846909ClinicalTrials.gov
• Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women#860221ClinicalTrials.gov
• The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood#862974ClinicalTrials.gov
• Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults#872041ClinicalTrials.gov
• Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant#903032ClinicalTrials.gov
• Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection#904862ClinicalTrials.gov
• Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.#321545ClinicalTrials.gov
• Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136#812391ClinicalTrials.gov
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)#849273ClinicalTrials.gov
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis#802649ClinicalTrials.gov
• Exploring HIV self-testing and implementation determinants among migrants: perspectives from West, East, Central, and Southern African migrants and key informants in the Netherlands.#9916PubMed
• Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach#373060WHO IRIS
• Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis#627349WHO IRIS
• A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients#804121ClinicalTrials.gov
• An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.#826630ClinicalTrials.gov
• A Study of HIV in Newly Infected Individuals#835141ClinicalTrials.gov
• The Mochudi Prevention Project ART Protocol#886999ClinicalTrials.gov
• The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)#896983ClinicalTrials.gov
• A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women#900118ClinicalTrials.gov
• A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors#881227ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults#429618ClinicalTrials.gov
• Operational considerations for preventing the mother-to-child transmission (PMTCT) of HIV in the 2013 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection#466863WHO IRIS
• Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador#900471ClinicalTrials.gov
• A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States#802365ClinicalTrials.gov
• A Study of Isoprinosine in Patients With Lymph Node Disease#899786ClinicalTrials.gov
• L-Carnitine to Treat Fatigue in AIDS Patients#907956ClinicalTrials.gov
• The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS#889626ClinicalTrials.gov
• Sexually Transmitted Infections Among African American Women Who Have Sex With Women#893917ClinicalTrials.gov
• Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach#373059WHO IRIS
• Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults#424233ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV#633772ClinicalTrials.gov
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT#813075ClinicalTrials.gov
• The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age#844994ClinicalTrials.gov
• Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT#879829ClinicalTrials.gov
• A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults#350000ClinicalTrials.gov
• Tool to set and monitor targets for HIV prevention, diagnosis, treatment and care for key populations: supplement to the 2014 consolidated guidelines for HIV prevention, diagnosis, treatment and care for key populations#373048WHO IRIS
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)#904840ClinicalTrials.gov
• A Study of Efavirenz in Combination With Stavudine and Didanosine#908558ClinicalTrials.gov
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B#811026ClinicalTrials.gov
• A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS#832108ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy#253159ClinicalTrials.gov
• Preventing HIV through safe voluntary medical male circumcision for adolescent boys and men in generalized HIV epidemics: recommendations and key considerations: web annex 5.2. case studies on enhancing uptake of voluntary medical male circumcision services#379675WHO IRIS
• A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss#874901ClinicalTrials.gov
• Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses#906665ClinicalTrials.gov
• Conception to child-rearing in the early treatment era (CONCRETE): a qualitative study of the experiences of women living with HIV during pregnancy and motherhood.#9870PubMed
• A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants#158021ClinicalTrials.gov
• Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach - 2010 version#376865WHO IRIS
• HIV, infant feeding and more perils for poor people: new WHO guidelines encourage review of formula milk policies#470968WHO IRIS
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)#825350ClinicalTrials.gov